Karen L. Noblett M.D., M.A.S.
Net Worth

Last updated:

What is Karen L. Noblett M.D., M.A.S. net worth?

The estimated net worth of Dr. Karen L. Noblett M.D., M.A.S. is at least $8,410,678 as of 31 Jan 2024. He has earned $4,502,278 from insider trading and has received compensation worth at least $3,908,400 in Axonics, Inc..

What is the salary of Karen L. Noblett M.D., M.A.S.?

Dr. Karen L. Noblett M.D., M.A.S. salary is $651,400 per year as Chief Medical Officer in Axonics, Inc..

How old is Karen L. Noblett M.D., M.A.S.?

Dr. Karen L. Noblett M.D., M.A.S. is 62 years old, born in 1963.

What stocks does Karen L. Noblett M.D., M.A.S. currently own?

As insider, Dr. Karen L. Noblett M.D., M.A.S. owns shares in one company:

Company Title Shares Price per share Total value
Axonics, Inc. (AXNX) Chief Medical Officer 34,428 $0 $0

What does Axonics, Inc. do?

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

AXNX logo
AXNX
Axonics, Inc.

Karen L. Noblett M.D., M.A.S. insider trading

Axonics, Inc.

Dr. Karen L. Noblett M.D., M.A.S. has made 12 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 11,288 units of AXNX stock worth $764,604 on 31 Jan 2024.

The largest trade he's ever made was exercising 27,500 units of AXNX stock on 31 Jan 2024. As of 31 Jan 2024 he still owns at least 34,428 units of AXNX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 11,288 $67.74 $764,604
Option
Performance-Based Restricted Stock Units 15,000 N/A N/A
Option
Common Stock 27,500 N/A N/A
Sale
Common Stock 15,999 $69 $1,103,963
Sale
Common Stock 7,051 $63.28 $446,180
Sale
Common Stock 949 $63 $59,787
Sale
Common Stock 136 $60.44 $8,219
Sale
Common Stock 795 $61.02 $48,508
Option
Performance-Based Restricted Stock Units 6,000 N/A N/A
Sale
Common Stock 2,167 $61.17 $132,553
Option
Common Stock 10,250 N/A N/A
Sale
Common Stock 1,536 $61.12 $93,883
Sale
Common Stock 10,454 $71.53 $747,796
Sale
Common Stock 13,531 $57.23 $774,366
Sale
Common Stock 6,343 $48.21 $305,796
Option
Common Stock 19,463 N/A N/A
Sale
Common Stock 339 $49.04 $16,623
Option
Performance-Based Restricted Stock Units 14,130 N/A N/A
Option
Common Stock 14,404 $1.31 $18,797
Option
Stock Option (Right to Buy) 14,404 $1.31 $18,797

Axonics key executives

Axonics, Inc. executives and other stock owners filed with the SEC: